We need your help! Has CancerModels.Org saved you time or effort?

Please take 15 minutes to fill in a survey and help EMBL-EBI make the case for why open data resources are critical to life science research.

Survey link: https://www.surveymonkey.com/r/QGFMBH8

Institut Curie - LIP - Lung Cancer

Institut Curie - LIP - Lung Cancer logo

The Pre-clinical investigation laboratory at the Curie Institute (LIP) has 25 years experience in developing patient-derived PDXs of a wide range of cancers including breast, colon, lung, ovary, uveal melanoma, retinoblastoma, Head and Neck cancers.

The Pre-clinical investigation laboratory is developing the next generation of PDX models, from drug-resistant tumors, metastatic cancer to humanized models. LIP services includes:

  • Preclinical pharmacology & pharmacodynamics of anti-cancer drugs
  • Identification of predictive biomarkers of response and resistance to anti-cancer agents
  • Collaboration with many national and European academics & pharmaceutical companies Read more

We have established a collection of heterotopic ovarian cancers PDXs.

The Pre-clinical investigation laboratory is a member of the EurOPDX Consortium. EurOPDX is supported by the European Union's Horizon 2020 research and innovation programme under the grant agreement No. 731105 EDIReX

See all Curie-LC models